Trifecta Capital Advisors
TWST icon

Trifecta Capital Advisors’s Twist Bioscience TWST Stock Holding History

Trifecta Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.6K Sell
65
-545
-89% -$67.3K ﹤0.01% 238
2026
Q2 		$62.8K Buy
610
+135
+28% +$8.78K 0.01% 180
2026
Q1 		$22.6K Hold
475
– – ﹤0.01% 201
2025
Q4 		$15.1K Buy
+475
New +$14.8K ﹤0.01% 208

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Trifecta Capital Advisors's TWST Position: Q3 2026 in Review

Trifecta Capital Advisors reduced its Twist Bioscience (TWST) stake by 89% in Q3 2026, selling an estimated $67.3K and leaving 65 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #238.

Trifecta Capital Advisors first reported a position in TWST in Q4 2025 and has held it in 4 quarters since. The position peaked at $62.8K in Q2 2026. 267 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Trifecta Capital Advisors held 65 shares of Twist Bioscience worth $12.6K as of Q3 2026.
  • Trifecta Capital Advisors sold 545 Twist Bioscience shares in Q3 2026, an estimated $67.3K.
  • Twist Bioscience made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q3 2026, its #238 holding.
  • Trifecta Capital Advisors first reported a position in Twist Bioscience in Q4 2025 and has held it in 4 quarters since.
  • Trifecta Capital Advisors's Twist Bioscience position peaked at $62.8K in Q2 2026.
  • 267 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Trifecta Capital Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.